Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

X4 Pharmaceuticals

http://www.x4pharma.com

Latest From X4 Pharmaceuticals

Scrip Asks…What Does 2022 Hold For Biopharma? Part 5: Clinical Trials

The COVID-19 pandemic drove huge shifts in clinical trial practice and the transformation is expected to continue even after the global health emergency abates. Industry leaders sharing their predictions around clinical development homed in on decentralized trials, digitization and data tools as key topics for 2022.

Scrip Asks Clinical Trials

Scrip Asks...What Does 2022 Hold For Biopharma? Part 1: Markets, Competition And Business Strategy

Biopharma industry leaders highlight key concerns and opportunities across production, supply chain and commercial operations. Business transformation is top of mind for many, perhaps unsurprisingly following two years of rapid and mostly successful adaptation to the strictures of the COVID-19 pandemic.

Scrip Asks Business Strategies

Hologic Adds Vessel Sealing Tech By Acquiring Bolder Surgical For $160M

Colorado-based Bolder recently announced the global launch of the CoolSeal vessel sealing platform, which will complement Hologic’s obstetrical/gynecological surgery product line.

M & A Gynecology & Urology

Hologic Makes Good On Mobidiag Acquisition With Expanded Launch Of Diagnostics Platform

Following the purchase of Mobidiag, Hologic has aggressively launched the Novodiag platform across Europe in a bid to dominate the local molecular diagnostics market.

Launches In Vitro Diagnostics
See All

Company Information

  • Industry
  • Biotechnology
  • Diversified
  • Pharmaceuticals
  • Pharmaceuticals
    • Chiral Chemistry
  • Biotechnology
    • Antisense, Oligonucleotides
    • Large Molecule
    • Liposomes
    • Nanotechnology, Chips, etc.
    • Pharmacogenetics-Pharmacogenomics
    • Synthesis Technologies, Production Processes
    • Transgenics
    • Large Molecule
      • Antibodies
    • Drug Discovery Tools
      • Bioinformatics
      • Molecular Diversity
UsernamePublicRestriction

Register